pSIREN-RetroQ-shN Citations (5)
Originally described in: BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands.Mayes K, Elsayed Z, Alhazmi A, Waters M, Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, Malapati P, Blevins T, Lisnic B, Dumur CI, Landry JW Oncotarget. 2017 May 12;8(38):64344-64357. doi: 10.18632/oncotarget.17834. eCollection 2017 Sep 8. PubMed Journal
Articles Citing pSIREN-RetroQ-shN
| Articles |
|---|
| BPTF Depletion Enhances T-cell-Mediated Antitumor Immunity. Mayes K, Alkhatib SG, Peterson K, Alhazmi A, Song C, Chan V, Blevins T, Roberts M, Dumur CI, Wang XY, Landry JW. Cancer Res. 2016 Nov 1;76(21):6183-6192. doi: 10.1158/0008-5472.CAN-15-3125. Epub 2016 Sep 20. PubMed |
| Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence. Yang C, Li Z, Bhatt T, Dickler M, Giri D, Scaltriti M, Baselga J, Rosen N, Chandarlapaty S. Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.379. PubMed |
| Delete_BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. Mayes K, Elsayed Z, Alhazmi A, Waters M, Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, Malapati P, Blevins T, LisniA B, Dumur CI, Landry JW. Oncotarget. 2017 May 12. doi: 10.18632/oncotarget.17834. PubMed |
| Delete_BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. Mayes K, Elsayed Z, Alhazmi A, Waters M, Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, Malapati P, Blevins T, Lisnic B, Dumur CI, Landry JW. Oncotarget. 2017 May 12;8(38):64344-64357. doi: 10.18632/oncotarget.17834. eCollection 2017 Sep 8. PubMed |
| MicroRNA-383 promotes reactive oxygen species-induced autophagy via downregulating peroxiredoxin 3 in human glioma U87 cells. Xu Z, Zeng X, Li M, Liao J, Chen Q. Exp Ther Med. 2021 May;21(5):439. doi: 10.3892/etm.2021.9870. Epub 2021 Feb 26. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.